Regenerative Injection Therapy Research
There are several exciting emerging forms of regenerative injection therapy. Platelet Rich Plasma (PRP) and Autologous Stem Cell therapy are used as non-surgical alternatives to treat orthopedic and other painful conditions using the patient’s own cells. Years of research has proven the efficacy of regenerative injection therapies such as PRP and stem cell and hundreds of studies are currently underway to further strengthen the findings.
The third option for regenerative injection therapy is the use of placental tissue-derived allograft that provides a structural matrix to facilitate tissue regeneration. The unique biologic structure of placental tissue provides a rich source of proteins, cytokines and growth factors. This abundant source of collagen provides an extracellular matrix to act as a natural scaffold for cellular attachment, providing clinical benefit to the patient.
For more information and details on past and current studies on regenerative injection therapies, see links to related articles below.
[col][pdf title=”Platelet Rich Plasma:” category=”Plasma”] [pdf title=”Autologous Stem Cell: ” category=”Usc”] [pdf title=”Allograft Placental Tissue:” category=”Placental”][/col]
“Dextrose and platelet-rich plasma solutions have shown to increase expression of growth factors in vivo and have shown promising clinical results in the treatment of tendinosis”. (Vora, A., Borg-Stein, J., Nguyen, RT, PMR 2012)